Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients wit
PDF) 3-D Conformal Photon Boost in the Treatment of Early Stage Breast Cancer: Four Year Follow Up Results | Ákos Horváth, Gabor Liposits, and Ferenc Lakosi - Academia.edu
PDF) Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review paper
Gabor Liposits, Physician at Helse møre og romsdal, molde hospital
OncoAlert - https://www.geriatriconcology.net/article/S1879... | Facebook
Fabio GOMES | Clinical Research Fellow | MD MRes | The Christie NHS Foundation Trust, Manchester | Medical Oncology
Gábor Liposits (lipositsg) on Pinterest
Media Tweets by Gabor Liposits (@G_LipositsMD) | Twitter
Young SIOG Leadership | SIOG
SKMBT_C28015090710520
Olaparib treatment in older patients with ovarian cancer: need for 'real-world' data beyond clinical trials - ecancer
Loop | Zsolt Liposits
Young SIOG Leadership | SIOG
Gabor Liposits (@G_LipositsMD) | Twitter
Tilbyr enda bedre kreftbehandling - rbnett.no - nyheter, sport, kultur og økonomi
Nicolò BATTISTI | Clinical Research Fellow in Medical Oncology - Specialty Doctor | The Royal Marsden NHS Foundation Trust, London | Department of Medicine - Breast Unit
Gabor LIPOSITS | PhD Student | University of Southern Denmark, Odense | SDU | Institute of Clinical Research
Young SIOG Leadership | SIOG
Gabor Liposits (@G_LipositsMD) | Twitter
Europæisk kræftorganisation udsteder særligt certifikat til Hospitalsenheden Vest
Geriatric oncology: the time is now - ecancer
